Company Filing History:
Years Active: 1999-2005
Title: The Innovations of Samuel Simon Ascuali
Introduction
Samuel Simon Ascuali is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medical science, particularly through his innovative use of hyaluronic acid in various therapeutic applications. With a total of two patents to his name, Ascuali's work focuses on preventing vascular complications in animals.
Latest Patents
Ascuali's latest patents include the "Use of Hyaluronic Acid and Forms to Prevent the Narrowing of the Vascular Walls" and the "Use of Hyaluronic Acid and Forms to Prevent Arterial Restenosis." The first patent addresses the prevention of narrowing in tubular walls of animals after trauma, advocating for the administration of a therapeutically effective non-toxic amount of hyaluronic acid or its salts. The second patent focuses on preventing arterial restenosis, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Ascuali has worked with various organizations, including Hyal Pharmaceutical Corporation and Jagotec AG. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical therapies.
Collaborations
Ascuali has collaborated with notable individuals in his field, including Rudolf Edgar Falk and Eva Anne Turley. These partnerships have likely enriched his research and development efforts, leading to impactful innovations.
Conclusion
Samuel Simon Ascuali's contributions to the field of medical science through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of therapeutic solutions in the medical community.